Crossing the Immunological Barrier

A man sits shaking on an airplane. Sweat soaks his face, his arms and legs shake
uncontrollably. Within hours of landing in California, the man lies dead, and hundreds of
people are infected with the same mysterious virus. In another scenario, a teenage boy
unknowingly sells drugs laced with a deadly viral strain. Terrorists threaten to release the
virus to the nation, causing the entire population to be eradicated within days.
These are the respective premises of the movie Outbreak and the television show,
24. Hollywood has always been fascinated by such apocalyptic themes. Biological
weapons and viruses are prevalent instruments used to create movies and shows that depict
chaos and mass destruction. Until September 11, 2001, the majority of people viewed these
depictions as highly exaggerated dramas. However, when the towers crumbled in New
York City, the public was faced with a frightening possibility.
News shows, magazines, and even the U.S. President, made dire predictions about
biological threats to national security. Most of the viruses that the government worried
about were animal disease strains. Anthrax, SARS, Monkey pox, West Nile virus… the list
goes on and on. But what is the likelihood of these diseases causing widespread illness and
deaths? This is the question experts are faced with today. This is also the inspiration for
writing this article.
The questions surrounding animal importation and diseases are varied and
complex. In fact, Hollywood’s portrayal of the problem is only one minor element of the
issue. This article is divided into four sections. First, the article provides a brief
background of problem. Second, the article discusses xenotransplantation and its risk of
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spreading diseases. Third, international trade laws are discussed in light of public health
concerns. Lastly, the article summarizes the findings of this article and introduces possible
prevention and control strategies.

Part One: Background of Zoonotic Diseases
“Zoonoses” is the term used to describe the transmission of animal disease to
humans through either airborne or physical contact.1 The dangers of zoonoses are
numerous. Often, the diseases that animals carry are latent and harmless while residing in
their bodies. However, once they are transmitted to humans, they may mutate into
dangerous or even deadly illnesses. Since animals carry pathogens that humans do not
possess, human immune systems are not well-equipped to deal with the onslaught of new,
foreign diseases. 2 For example, Macaque herpes is harmless to Macaque monkeys, but
lethal to human beings.3 Similarly, Ebola outbreaks in Sudan, Zaire and the U.S. have been
linked to crossing the animal to human immunological barriers. 4 Most recently, the world
watched as the latest evidence of cross-barrier viruses proved deadly when Europeans
digested meat infected with Foot and Mouth Disease (FMD).5
FMD is an extremely virulent disease because it can flourish in almost any
condition. 6FMD can be transmitted via saliva, feces, mucus, milk, tissue, urine, blood or
air. Unlike mad cow disease, with which it is most often confused, FMD is usually
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harmless and rare among humans. Nevertheless, its impact upon world politics was felt in
February 2001, when the first case was confirmed in the England. Soon after, exports on
alllive animals, meat and dairy products were banned. Farmers across the continent began
the mass slaughter of infected animals, and crops were burned to prevent further outbreaks.
So while FMD is not as physically damaging to humans as BSE, the consequences of the
disease are still severe.
BSE is a prion disease discovered and documented by Nobel Laureate Stanley
Prusiner.7 Prion cells are present in all vertebrates, but in BSE, they mutate and slowly
erode brain cells. BSE is a degenerative neurological disorder that is common in bovine.8
Since its origin is unknown, it was initially difficult to recognize the disease during the
first ten years of its outbreak. It was not until Europeans began to die tragically in 2001
that the world learned of mad cow disease. BSE's human form is Creutzfeld-Jakob disease
(CJD).9 CJD has caused ninety-four human deaths in Europe in recent years.10 This
occurred when humans ate meat from cows that were infected with BSE.11 Humans
infected with CJD suffer from loss of memory, tremors, hallucinations, weakness, and
eventually cannot talk or walk. There is no known cure for the disease.
At the moment, BSE is considered to be a European problem, sincet here are no
known cases in the United States. This is mainly due to the United States’ quick prevention
strategies. Soon after the outbreak was confirmed to be linked to meat, the United States
banned its importation. Nevertheless, the possibility that such a disease could permeate our
borders has raised several concerns about the efficacy of food and animal centers.
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Bovine diseases are only one type of zoonoses. Other illnesses include West Nile
Virus, dengue fever, anthrax and SARS. Since these are all infectious diseases, they are
often classified as emerging infectious disease or EID. Examples of EID include typhoid,
smallpox and malaria. These diseases are better documented and recognizable than
zoonotic diseases because their existence dates to early existence. Thus, zoonoses poses a
greater problem than regular infectious diseases because it is still an uncharted territory. As
new diseases emerge, scientists work hastily to discover their origins, symptoms and how
to contain them. In the meantime, the EID infects and spreads unhindered. Most
importantly, zoonotic diseases pass human immune systems and take root within the
human body. In most instances, this permeation occurs unintentionally through physical or
airborne contact. However, in the case of xenotransplantation, permeation may occur
willfully when patients subject themselves to this procedure.

Part Two: The Interesting Problem of Xenotransplantation

1. Background
Xenotransplantation is an innovative medical procedure in which tissues, organs,
body fluids and cells from animals are transplanted into humans.12 Xenotransplants
perform the same functions as the human materials they replace. The procedure is intended
as a solution to the shortage of human organs (allotransplants).13 End-stage organ failure is
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the most critical health problem facing Americans today.14 Currently, more than 65,000
people are on the national organ transplant waiting list.15 Approximately 4,000 of them die
annually while waiting for a suitable organ transplant.16
Heart failure cases provide another potent example of the insufficient supply of
organ transplants. Heart failure kills four times more people than HIV infection.17 The
most effective remedy to heart failure is transplantation. Unfortunately, the demand for
organ donations far exceeds its supply. It is estimated that only 2,000 human hearts are
available annually for approximately 45,000 patients who could use them.18 Given these
statistics, it is little wonder that scientists have tried to devise alternatives to human organ
donations. The most popular choice has been to turn to animals for organ donations.

2. History
Cross-species transplantation dates back to the early twentieth century, when
kidney xenografts of rabbit, pig, goat, primate and lamb donors were used.19 After a series
of fatal procedures, however, scientists did not attempt further procedures until the 1950s.
In 1954, Drs. Murray, Harrison and Merrill performed the first successful human kidney
transplant between identical twins at the Brigham Hospital in Boston Massachusetts.20
Twenty years later, the first successful heart transplant followed suit.21 Unfortunately, the
lives of these recipients were often not extended beyond a few days. In fact, the longest
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survivor at that time was a newborn baby with hypoplastic left heart syndrome. “Baby
Fae” received a mismatched ABO-blood group baboon heart that only functioned for 20
days.22
Initially, primates were the chosen donors because they are the most similar species
to human beings. 23Scientists hoped their anatomical structures would be so compatible
that immune rejection would not occur. However, these attempts were largely
unsuccessful.24 Their failure was due to the fact that primates do not have Type O blood
types (the universal donor) and cannot be bred in large colonies.25 Additionally, numerous
animal rights organizations decried the practice. They claimed it exploited animals that had
similar structures, feelings and thought processes of human beings.

3. Using Pigs as Donors
Undeterred, scientists then looked to pigs for potential donorship. Pigs, particularly
miniature swine, are most desirable because their organs are similar in size and anatomy to
humans.26 Additionally, they are abundant and generally accepted as a source of food,
clothing and goods.27 Therefore, the use of pigs does not garner the same level of
controversy that primates do. In fact, the Nuffield Bioethics Committee concluded in its
second report that using pigs was ethical while using primates was not. 28
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However, the main obstacle with using pigs as donors for xenotransplantation is
that all pigs are born with two copies of a gene that create a sugar molecule that attaches to
cell surfaces.29 This molecule, called alpha-1-galactose, is very similar to a bacterial sugar.
Thus, when a pig organ is inserted into a human body, the human immune system releases
antibodies to aggressively fight the foreign substance. This inevitably leads to rejection of
the organ within a matter of minutes. 30
In response to this problem, scientists have genetically altered pig organs to
become more compatible with humans. In February 2003, a Wisconsin biotech firm,
Infigen, claimed it had genetically engineered and cloned a litter of three miniature swine
in which both copies of the gene that creates alpha-1-galactose-have been suppressed.31
This recent development has major repercussions. Like the cloning of Dolly the sheep, it
allows for the creation of more genetically engineered creatures. By creating pigs that can
theoretically be transplanted into humans without being rejected, Infigen has leapt forward
into a new age of transplantation. The consequences of this discovery are numerous. With
them come increased responsibilities and legal concerns.

4. The procedure
The first step in the process of xenotransplantation is to find a suitable animal
donor. Just as in allotransplantation (the procedure of transplanting organs from one
human to another), recipients receive drugs after the transplant to reduce the risk of
immune rejection. Unfortunately, the use of immunosuppression drugs makes the recipient
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more susceptible to ordinary diseases. Usually, when an organ is transplanted, some level
of rejection occurs despite the compatibility of the match. The use of non-human organs
heightens the risk of such rejection. It also elevates the need for immonsupression drugs,
which increases the recipient’s chances of infection and illness. “[T]transplanting a nonhuman primate organ into a human recipient will require a greater level of
immunosuppression in the recipient than the same procedure involving a human organ; and
a pig organ will involve an even greater level of immunosuppression in the recipient than
the organ from the non-human primate”.32
Furthermore, the traditional barriers of skin, immune systems and gastrointestinal
tracts that protect humans from the spread of infections are circumvented when
xenotransplantation takes place. Thus, animal diseases are essentially imbedded into the
natural make-up of a human being. Since pigs are vastly different than humans, the crossspecies barrier that is being circumvented is so wide that the potential for diseases is
greater.33 One of the greatest risks to xenotransplantation with pig organs is that a pig virus
may infect the human recipient and mutate.
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The disease is even more dangerous because it is difficult to quantify the risks it
poses to humans. Since no solid pig organ has yet been transplanted into a human, it is
impossible to ascertain exactly what risks human may encounter. By the same token, it is
also impossible to develop drugs or safeguards against such potential risks. In a worst case
scenario, if solid pig organs are transplanted without safeguards, PERV and other diseases
could not only infect the recipient’s immune system but also all friends, family members,
and others s/he may come in contact with.37
Even if the strictest safeguards are enforced, xenobiotechnology will always carry
the risk of introducing and spreading zoonotic diseases. Besides PERV, pigs are known to
have at least 25 diseases that can be transmitted to humans.38 For instance, the deadly
human influenza virus in 1918 that killed approximately 20 million people worldwide was
a mutation of a swine flue virus.
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Malaysia in late 1998, spread from pigs to hundreds of humans.40 This led to the mass
slaughter of some one million pigs, as well as several dogs and horses.
Although many critics argue most claims about possible xenotransplant outbreaks
are unsubstantiated, some facts are undisputed. Scientists know viruses can infect one
organism while passing to another. They also know a virus that is harmless in one species
may be lethal in another. HIV, the human immunodeficiency virus, is one example of this
risk.41 Many researchers believe HIV originated from primates.42 These scientists believe
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HIV is a simian immunodeficiency virus(SIV) that crossed the species barrier in Africa.43
If this is true, primates have never suffered the devastating effects of HIV that humans
have. So HIV, like other cross-species viruses, is more dangerous in humans than in its
original animal hosts. Similarly, monkey pox, Ebola and other viruses are prevalent among
monkeys.44 When they passed to human beings, though, the consequences have been
terrible.
Dozens of such infections have been documented in journal articles of the last
decade. The major problem with zoonoses is that it creates unforeseeable health risks for
both the recipients and the general public. The basic structure of these diseases lends itself
to mass outbreaks. Since the diseases are often latent and highly contagious, it is easy for
an infected individual to spread the disease to family, friends and community members.
Also, the fact the procedure is so new makes it is difficult to evaluate exactly how great
this risk is.

5. Prevention and Control
These sobering facts have led this author toconclude t hat xenotransplantation
undermines any real efforts to control infectious diseases. With the increased awareness of
animal diseases, the potential for outbreaks has become a very serious possibility. Thus,
the need for legally viable safeguards against these dangers is substantial. In order to
minimize the possibility of more outbreaks, the federal government must increase its
regulation of xenotransplantation.
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In 1996, the Centers for Disease Control (CDC), the Food and Drug Administration
(FDA
) and the Department of Health and Human Services (DHHS) published a set of
guidelines for xenotransplantation.45 It suggested all xenotransplantation procedures should
be regulated under new FDA investigational new drug regulations and informed consent
laws.46 However, the FDA has not yet adopted these guidelines. Nonetheless, the
guidelines are useful when trying to determine what safeguards can be placed on
xenotransplantation.
The guidelines suggest the federal government should provide for specially
designated teams that monitor data, tissue storage and surveillance. It also recognizes the
need for government regulated clinical facilities, protocol reviews, informed consent
regulations and the maint enance of animal donor populations. 47 Such prevention strategies
are an important step, but pose several legal and ethical dilemmas.
a. Surveillance
Most commentators agree that any attempt to control the spread of infectious
disease requires a surveillance system. However, it is important to recognize such a system
would not prevent the spread of disease on its own. Due to the nature of these diseases,
many infections can spread, undetected, even under the most rigorous surveillance system.
Furthermore, a system designed to monitor the progress and movement of individual
recipients could clash with basic fundamental rights. For example, the rights to travel,
movement and privacy would necessarily be infringed by such a system. These rights have
been historically recognized and honored bythe U.S judicial system.
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In Apetheker v. Secretary of State, for example, the U.S. Supreme Court held the
right to travel was a fundamental right protected by the due process clause of the 5th
Amendment.48 It further stated: “freedom of movement across frontiers in either direction,
and inside frontiers as well, was a part of our heritage. Travel abroad, like travel within the
country, may be as close to the heart.as the choice [] to eat, wear or reads”.49 On the other
hand, Zemel v. Rusk recognized the government’s right to restrict some travel when flood,
pestilence or other natural disasters threaten public safety.50 Therefore, when the risks of a
disease are obvious, the government should be allowed to limit an individual’s 1st
Amendment and due process rights. However, the true dilemma occurs when the risks of a
disease are speculative. In these cases, the government cannot justify its actions without
ample proof of its necessity. This is the dilemma xenotransplantation poses. This also
explains the FDA’s current reluctance to impose a surveillance program that may infringe
upon these rights. Until further research is conducted, it is difficult for the government to
implement preventive programs that will honor case precedent.
In recognition of the need to impose public safety measures, the United Kingdom
has adopted guidelines for a surveillance system that can serve as a model for the United
States.51 The UK proposal enables quick detection, management and investigation of
possible infectious diseases emerging from xenotransplantation. It requires recipients to
agree to: (a) regular samples of bodily fluids that are then tested for disease; (b) refrain
from donating blood, organs or tissues; (c) register their name and address on a national
registry at all times; (d)post-mortem analysis; and (e) divulge all confidential information
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to health care officials.52 Theoretically, such a model could help stop the spread of
infectious animal diseases. However, can any government really sustain such an extensive
program? Considering the procedural and monetary logistics involved, one has to ask
whether such a system would place an undue burden upon individuals and the government.
Also, how can such a proposal be reconciled with constitutionally guaranteed rights?

2. Informed Consent
Proponentsof xenotransplantation argue the balance between protecting individual
constitutional rights and the duty to maintainpublic health can be achieved through
comprehensive informed consent procedures. . Even a cursory look at health law cases
would illustrate, however, that informed consent is not such a simple alternative. Informed
consent in other areas of health law, such as drug testing, abortion and clinical trials, has
often resulted in complex and protracted litigation. This is partly due to the vulnerability of
patients who purport to give their informed consent. As sick and desperate individuals,
many patients do not possess the sound mind or body to givetheir consent . A patient’s
debilitated condition exposes his/her susceptibility and vulnerability. Often the patient’s
desire to recover from the disease clouds any rational judgment. In short, a patient who is
dying from organ failure and suffering from excruciating pain may consent to almost
anything to recover from his/her fate. Under such circumstances, can any informed consent
be legitimate?
Furthermore, informed consent laws work best with known diseases that can
predict known outcomes. In such cases, physicians can thoroughly explain a diagnosis and
the patient’s options. The patient can then research and weigh those options intelligently.
52
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In the case of xenotransplantation, however, this is not possible. A patient essentially
would place his/her life in the hands of a scientist who also cannot assess the risks
associated with the procedure. First, there is no conclusive scientific data about the side
effects of xenotransplantation. Even its success at prolonging one’s life is not guaranteed.
Second, its impact upon public health has not yet been ascertained. Therefore, a patient
may be subjected to regular tests, scrutiny and surveillance without fully understanding the
associated consequences.

Patients’ Rights
The informed consent doctrine is premised on the patient’s right to know and the
right to self-determination. In the instance of xenotransplantation, both rights are infringed.
First, a physician has a duty to inform the patient of the nature of a proposed procedure, its
nature and risks. Second, a patient has the right to accept or forgo treatment after reviewing
the information. As stated earlier, this process cannot occur with xenotransplantation.
Unless more is learned about this clinical procedure, it is impossible to gain informed
consent.
Nuremburg Code
The notion of informed consent was developed after World War II, when the world
learned that Nazis had performed experimental medical procedures on unwitting prisoners.
During the Nuremburg trials in December 1946, sixteen German defendants were
prosecuted for war crimes and crimes against humanity during the Nazi reign and
convicted by an American court. The greatest legacy of those trials was the creation of the
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Nuremberg Code, a set of ten principles laid out by the judges who decided the case. 53The
Nuremberg Code is significant worldwide because it directly limits the purpose and effects
of human experimentation. After the horrors of unregulated medical experimentation were
revealed, the Western nations agreed that such a Code was vital to preventing further
cruelty against human beings.
The first principle of the Nuremberg Code asserts “the voluntary consent of human
subjects is absolutely critical”.
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For the aforementioned reasons, this tenet of the Code is

violated by the advent of xenotransplantation clinical trials. Informed consent cannot be
achieved in such a volatile environment. Given the experimental nature of the procedure,
the risk of preying on vulnerable patients is great. Xenotransplantation may give patients
false hope about their recovery. This pretense may propel patients to consent to procedures
they normally would not agree to. Also, insufficient date prevents physicians from fully
explaining the risks of consequences. As a result, informed consent cannot be achieved.
Additionally, xenotransplantation violates the second Nuremberg principle. That
principle states any experiment should “yield fruitful results for the good of society”.55 As
explained, transplanting pig (and other animal) organs into human beings erodes the
natural barrier between human and animal species. Thus, disease and infection are given
full reign of the human immune system. The consequences of this transplantation are
enormous since the diseases that humans may acquire are highly dangerous and
contagious. Thus, recipients, their families, friends and society are put at risk when
xenotransplantation takes place.
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Each of the Nuremberg Code principles is nullified by the participation of humans
in the xenotransplant clinical trials. Nowadays, the Nuremberg Code is not used as decisive
legal authority. Nevertheless, it serves as a guidepost for national regulations on
experimental procedures. Critics argue the Code, and its principles, restrict the
advancement of biotechnology. Scientists feel particularly constricted by the first and
second principles of the Nuremberg Code. Experimental procedures are always uncertain
explorations into unknown realms. Thus, they argue adherence to these principles hinders
their development.
Nevertheless, the Nazi experiments and the recent Tuskegee controversy should
demonstrate the need to abide by the Nuremberg principles.56 In order to maintain human
dignity and integrity, it is vital that world governments adopt some semblance of the
Nuremberg Code in their supervision of experimental procedures.

b. Third Party Consent
Even if patients are able to give their informed consent, it would be impossible to
obtain consent from all third parties involved. A xenograft recipient not only places
himselfin danger of infection, but all those s/he comes in contact with as well. Thus, by
the definitions of human rights laws, every third party who may be exposed to an
infectious disease must consent to such a risk.57 Otherwise, an unconsented exposure to
health risks would violate the tenets of the Nuremberg Code, the 1964 U.N. Helsinki
Declaration and other declarations.
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c. Temporary Solution
Given these problems, a moratorium must be placed on xenotransplantation
procedures until the risks of infectious disease can be assessed and controlled. Without
such a moratorium, the government places its citizens at risk of contracting dangerous
infectious diseases. While the benefits of xenotransplantation are clearly recognizable, the
risks of such a procedure are too great to proceed. Nonetheless, the issue of
xenotransplanta tion is just one facet of the problem of animal infectious diseases.

Part Three: International Trade Laws

1. Public Health, Economy and Migration
While a discussion of xenotransplantation is mostly hypothetical at this stage, the
global impact of animal infectious diseases is documented proof of the need for control
and prevention. As stated, disease outbreaks can have far-reaching consequences on global
trade and economy. When a disease like mad-cow disease infects the human population,
prices in food, medicine and stocks plummet. Other areas of public health are also affected.
For example, when FMD infected the meat in Europe, surgical centers in New York
suffered.58 Since that outbreak, surgical centers couldn’t receive blood donations from
Europe so their blood supply has seriously diminished.
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a ban on all live animal and meat imports. This widespread ban resulted in an economic
loss of $250 million.60
The USDA, CDC, the National Institute of Health (NIH) and the FDA, work
together to protect Americans from diseases associated with animals. Although the
aforementioned disease pose significant threats to a person’s well-being, other diseases are
dangerous economically. For example, FMD is economically disastrous for
underdeveloped nations. Since a FMD vaccine is available, many countries can implement
extensive vaccination programs for their livestock. However, such a program can cost
billions of dollars. Therefore, it is almost impossible for developing countries to employ.
However, if these countries decide not to vaccinate its animal population, it faces
embargos from other countries and a loss of its entire trade supply.61

2. NAFTA and GATT
International trade with the United States is governed by both NAFTA (North
American Free Trade Agreement) and GATT (General Agreement on Tariffs and Trade).
With the adoption of these treaties, the trade of livestock and livestock products among
member nations has grown.62 The main concern with this increase is that animal diseases
will spread faster and wider as a result. Since the implementation of NAFTA and GATT
naturally heighten the risk of animal importation disease, this article must explore these
treaties.
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During the Tokyo round of GATT negotiations in the 1970s, member nations
agreed to devise a “Standards Code” that would help nations adopt international standards
to suit their needs.63 The result of the conference was two agreements which are in
existence today. The Agreement on Technical Barriers to Trade (“TBT”) requires that
regulations have a legitimate objective that is not “trade restrictive”. SPMS (Sanitary and
Phytosanitary Measures) instructs members to protect human or animal life from the
spread of disease.64 Nations, including the United States, use SPMS as justification for
laws they impose against certain animals or products.
Both treaties contain provisions about SPMS that could potentially affect the
migration of animals from one country to another. SPMS measures are defined as any
measure applied to “protect animal or plant life or health within the territory of the
Member from risks…”65 All SPMS measures must be based on scientific evidence that
supports the level of protection the Member chooses.66 However, these stricter “scientific
requirements” are not always met when the US imposes embargos on particular animals or
by-products.
Risk Assessment and Scientific Requirement
NAFTA and GATT allow Member states to determine their own levels of
protection from public health risks. However, this level must be justified by sound
scientific evidence that the risk is viable and imminent. The levels of protection must also
be based on “risk assessment”. This means Members must evaluate the likelihood of entry
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and the spread of disease.67 Such a test was intended to prevent one country from unfairly
placing embargoes upon another. In the spirit of free trade and democracy, the treaties
hoped to eradicate prejudices and politics from the arena of international trade. In light of
animal importation and diseases, however, the requirements for scientific evidence can be
problematic. For those Members concerned about adhering to NAFTA and GATT, bans
on foreign animals and substances can only be placed after extensive scientific evidence is
gathered, documented and approved. Naturally, this poses a dilemma for a country faced
with an emergency situation.
If a country is faced with an epidemic arising from xenotransplantation for
example, it may be very difficult to obtain the requisite scientific evidence. Since such an
epidemic has never occurred before, scientists would be hard pressed to speculate about the
likelihood of its entry/departure into the country or its spread. Thus, by the definitions of
NAFTA and GATT, the United States would not be justified in imposing a ban on travel or
trade. So while the United States tries to sort out these logistics, infected persons or
animals could move freely between countries, infecting others in their wakes. What
international trade laws seem to ignore is most animal diseases insidiously creep into a
human’s immune system without timely detection. Thus, it is tremendously challenging for
a Member to provide a “scientific requirement” every time it plans to contain a disease.
The test posed by NAFTA and GATT illustrates the difficulty nations face when they
balance their duty to protect their citizens while simultaneously obeying international trade
agreements.
Furthermore, debates arise over whether such stringent scientific requirements are
even necessary or prudent in this modern time of communicable diseases, increased travel
67
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and bioterrorism. Some critics of SPMS and other international laws believe scientific
requirements actually endanger public welfare. For example, if a country receives a
potential threat of an animal bearing a deadly disease, such as anthrax, it must first undergo
a series of serious tests to prove such a threat is viable and imminent. Under the WTO, a
member state must first prove the risks are scientifically approved.
While authorities undergo such tests, critics argue, the animal may continue to be
imported into the USwhile a country tries to justify its ban. Such requirements may prove
to be very costly to a country that is constantly deluged with imports. If each potentially
harmful item must be a lengthy inspection before being banned from importation, the law
may defeat its intended purpose. This article recognizes the need for scientific
requirements to prevent discrimination among foreign suppliers. However, it proposes that
this test must be considered within an international context.68
It is important to note that a regulation that restricts foreign trade in order to protect
publichealth and welfare is generally given some level of discretion. The Appellate Bodies
of most countries have respected the rights of member nations to determine their own risk
levels.69 Nonetheless, this risk assessment test forces Members to identify the disease and
its consequences and prove its likelihood to spread via the banned product.

Australia-Salmon Case
This test was illustrated in the Australia-Salmon case. In that instance, Australia
had developed a successful salmon industry. As a result, it banned the importation of
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foreign salmon claiming it would infect domestic fish with certain diseases. 70 Canada
challenged this ban, claiming it did not meet “risk assessment, as defined by the SPMS
Agreement. Upon reviewing the charge, the Appellate Body considered factors listed
within the SPMS Agreement. These factors state riskassessment m ust identify the disease,
evaluate its likelihood of entry and determine the probability of its spread according to
certain SPMS guidelines. 71 The Appellate Body concluded Australia met the first prong of
risk assessment because it identified the diseases associated with the importation of foreign
salmon. Nevertheless, Australia did not meet the second prong because it could not
describe the likelihood of the disease entering and spreading within the nation.
Consequently, the Appellate Body in the Australia-Salmon case recognized that
any regulation prohibiting free trade of goods and services without ample scientific proof
of its adverse health effects may be classified as a “technical barrier of trade”. These are
domestic regulations that disadvantage or exclude foreigners from local markets.72 The
most obvious technical barrier to trade is a ban on foreign products that discriminates
between various suppliers.73 Facially nondiscriminatory regulations can also fall within
this definition. For example, if a regulation requires foreign suppliers to undergo greater
scrutiny, this may be classified as a technical barrier as well. Under this doctrine, facially
discriminatory and nondiscriminatory regulations may have the same effect on
international trade. Thus, the World Trade Organization has imposed obligations upon
domestic regulations that extend beyond nondiscrimination requirements.
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3. The World Trade Organization (WTO) and Globalization
The WTO is the organization responsible for maintaining proper trade relations
between Member nations. It was partly created to prevent such discriminatory behavior.
Like its predecessor, GATT, the WTO intended to unify nations and equalize any
disparities between suppliers. Essentially, the WTO forbids Members from discriminating
against foreign suppliers.74 One way it achieves this goal is by imposing the “scientific
requirements” test.
While imposing this restriction on its Members, however, the WTO faces a tension
between its respect for national sovereignty and its desire to unite Members. When it was
originally devised, the WTO was touted as a regulatory system that was respectful of the
sovereignty of each of its Member nations. In light of the growing problem of infectious
diseases, the WTO cannot adhere to this original notion. Any meaningful scientific
requirement regulation must necessarily infringe upon national sovereignty. If it does not,
then the WTO and its agreements would be rendered meaningless.

Globalization
In order to reconcile these two duties, the WTO must redefine its concept of
globalization. Globalization typically refers to a series of procedures that limit a state’s
ability to control actions within its own border.75 Depending upon the status of an
individual state, globalization can be viewed positively or negatively. For countries like the
United States, globalization is generally a progressive step towards international
cooperation, integration of financial markets and better foreign relations. For developing
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countries, however, globalization can be viewed as a hindrance to national sovereignty,
since it undermines their power over their own citizens. Moreover, unlike the United
States, lesser nations do not have the power to challenge the WTO if a regulation does not
suit their needs. Therefore, they are more obliged to follow global norms.
In the public health context, globalization creates several problems. Most public
health experts agree that traditional notions of national sovereignty cannot coincide with
the emergence of infectious diseases. 76 For example, globalization has caused historical
borders between European countries to erode into a melting pot of Schengen states. The
Schengen agreement enables the free travel and movement of citizens between all
participating states. Rooted in the laudable ideas of unity and equality, the “Schengen area”
was created when France, Germany, Belgium, Luxembourg and the Netherlands agreed to
become a territory without internal borders in 1985.77 The "Schengen area" took its name
from the town in Luxembourg where the first agreements were signed. In 1997, this
intergovernmental cooperation included 13 countries. More nations are continually added.
Adopted to create a stronger, more unified European unit, the “Schengen area” has
been heavily criticized by traditionalists. Considered within the public health debate, the
“Schengen Area” may provide fertile ground for infectious diseases to grow unhampered.
Part of the Schengen agreement includes a removal of checks and inspections at common
borders. These are now replaced by external border inspections. Consequently, travelers
are only checked when entering and leaving the entire “Schengen Area”. This may pose a
problem since travelers within the area move between vastly different climates and
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conditions. Such a variety in temperatures and environments can breed more infections and
diseases. Thus, the “Schengen Area” is the perfect illustration of the adverse effects that
globalization has on public health and safety.
Another example of effects of globalization is the recent Severe Acute Respiratory
Syndrome (SARS) epidemic. SARS is a viral respiratory illness that was first reported in
Asia in February 2003.78 Within a few months, the illness spread to more than two dozen
countries in North America, South America, Europe, and Asia.79 Due to increased
surveillance and stricter border inspections, the SARS outbreak was successfully
contained. Nevertheless, the quickness of its spread should serve as a grim warning to the
WTO and its Members of the impact of globalization in the public health context.
Globalization has allowed dangerous pathogens to break the walls which once
separated one nation from another. Infectious diseases have left illness and death in their
wake. They follow no pattern and respect no borders. Now, even immunological barriers
are eroded as cross-species diseases continue to spread. Thus, all species and nations are at
risk of disease outbreaks. The spread of infectious diseases is no longer a problem confined
to one nation. It must be addressed by an international community dedicated to
maintaining the health of all persons, not just the citizens of any given country. This can
only be achieved if the WTO, and other international organizations, make a concerted
effort to protect public health and safety even at the expense of national sovereignty.
Recognizing that the problem of animal diseases, and other infectious diseases, is a global
problem is the very first step.
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Conclusion
The issue of animal diseases touches upon several facets of health care law. Any
discussion of zoonoses must explore the need for international cooperation and federal
regulation of experimental trials. When discussing xenotransplantation, it is imperative that
one recognize the risks involved in such a procedure. Thus, every government must
undergo a risk-benefit analysis to determine whether xenotransplantation should proceed.
Undoubtedly, the goals of xenotransplantation are laudable. There is little question
that the health care system is plagued by an organ donation shortage. Artificial organ
transplants do not seem to be a viable option. Thus, animal organ donations may help fill
this void. At no time does this article suggest that xenotransplantation cannot take place in
the future. It only maintains that the procedure should not progress until adequate data and
research are complied. A moratorium should be placed on xenotransplantation until the
federal government and its state regulatory bodies have assessed all the risk involved and
devised appropriate preventive measures. If we refuse to proceed in this cautionary
manner, zoonotic outbreaks may be in our near future.
Given the widespread consequences of zoonotic diseases, international cooperation
is critical. Even if one country adopts stringent prevention and control mechanism, it can
still be susceptible to an outbreak. This is because citizens from that country can freely
move to other less cautious nations. Loose regulations and mechanisms can allow people
to pick up diseases as they move from one region to another. Hence, it is highly beneficial
that an international network is established to prevent the spread of diseases. Infectious
diseases do not discriminate between nations. They apply equally to every nation, person
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and culture. They also affect all aspects of life. Disease outbreaks can undermine
migration, world economy, public health and travel.
In short, it is vital for the integrity of our global system to devise a comprehensive
course of action against the spread of zoonotic diseases. This can only be achieved once
the WTO and all international organizations decide to place public health concerns above
other matters. Once these organizations realize that national sovereignty can be reconciled
with maintaining public health, the risk of zoonotic diseases can be significantly
diminished.
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